UNLOCKING A NEW SOURCE OF MICROBES TO IMPROVE HUMAN HEALTH
The Food as Medicine™ Company
Solarea Bio is a biotech company in Cambridge MA building solutions for health disorders using bacteria and fungi native to healthy foods to create powerful synergistic, anti-inflammatory microbial assemblages.
Launched at the Illumina Accelerator in 2017, Solarea has built a powerful platform using microbial discovery and genomics to rapidly deliver novel products to prevent the onset or progression of health problems associated to chronic inflammation.
Solarea Bio is creating a new class of health products by mining the microbes that naturally colonize healthy foods to address inflammatory disorders
Inspired by nature and using computational and experimental approaches bacteria and fungi are combined with other natural substrates to create functional and specific consortia
Our vision is to create and lead a new way to rapidly discover, develop and launch commercial products helping in the health management of disorders where other products are not sufficient
News & Press
Solarea Bio Announces Licensing Agreement with ADM
Solarea Bio, a biotech company based in Cambridge, MA that is developing microbial-based solutions to aid human health, today announced it has signed a technology licensing agreement with global nutrition leader ADM
Oct 19 2021
Solarea Bio rounds out management team to gear up for commercialization of first product
Solarea Bio, a company launching microbiome products to combat inflammatory conditions and improve the lives of afflicted individuals, rounds out their management team with strong startup commercialization experience as they welcome Dr. David Easson, Chief Manufacturing Officer and …
Oct 07 2021
Solarea Bio Announces Series A Financing
Solarea Bio announced today it has raised $11.2M in a Series A financing led by S2G Ventures and Bold Capital Partners, along with continued investment from Viking Global and additional investment from the Gisev Family Office as a syndicate …
Oct 19 2020
Welcome Solarea Bio: Innovators Unlocking the Power of Microbes to Improve Human Health
S2G’s investment into Solarea provides an opportunity for S2G to support the next wave of functional foods. S2G’s led Solarea’s Series A fundraise with Bold Capital Partners, along with continued investment from Viking Global Investors and the Gisev …
Oct 19 2020